ISSN: 2155-9899
+44 1223 790975
Mads Hald Andersen
Department of Hematology, Center for Cancer Immune Therapy, 54P4, Copenhagen University Hospital, Herlev, Herlev Ringvej 75, DK-2730 Herlev, Denmark.
His research interests include the characterization of novel tumor antigens, derived from proteins playing an important role for tumor cell growth and/or survival to avoid the selection of antigen-negative tumor cells during immunotherapy; the monitoring and description of T-cell responses in cancer patients both in preclinical and clinical settings.